Published: 2017-05-25

Relapse of cervical cancer 12 years after the treatment

Pedro Vieira Enes, Pedro Brandão, Juliana Rocha, Ana Rita Pinto, Fernanda Costa


Cervical cancer is the third most common gynecologic cancer in women and it remains one of the main causes of death. With rare exceptions, it results from an HPV infection and about 5% of this infection will culminate in the development of CIN 2 or CIN 3 lesions. After treatment with surgery or radiotherapy, 10 to 20% of the patients will have a relapse and/or metastases usually in the first two years after completing their treatment. In this article, we present a clinical case of a lymph node relapse 12 years after treatment in a 43-year-old patient with a microinvasive cervical cancer history, Figo stage IA1, without lymphovascular invasion.


Cervical cancer, Relapse, Treatment relapse

Full Text:



Frumovitz M, Goff B, Dizon DS. Invasive cervical cancer: Epidemiology, risk factos, clinical manifestations and diagnosis. UptoDate [update Feb 09, 2017]. Available at:

Registo Oncológico Nacional 2010. Available at:

Mota F. Cervix cancer; Compendium of Gynecology. Oncology. 2012:145-189

Boardman CH, Huh WK. Cervical Cancer. Emedicine [update Nov 02, 2016]. Available at:

National Cancer Institute. Oral Contraceptives ans Cancer Risk. [Apr 16, 2012]. Available at:

Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecologic Oncol. 1990;38(3):352-7.

Zaino RJ, Ward S, Delgado G, Bundy B, Gore H, Fetter G, et al. Histologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix: a gynecologic oncology group study. Obstet Gynecol Surv. 1992;47(9):638-9.

Burghardt E, Baltzer J, Tulusan AH, Haas J. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer. 1992;70(3):648-55.

Stehman FB, Bundy BN, Disaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy I. A multi‐variate analysis of prognostic variables in the gynecologic oncology group. Cancer. 1991;67(11):2776-85.

Friedlander M, Grogan M. Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist. 2002;7:342-7.

Leitao MM, Chi DS. Recurrent cervical cancer. Curr trat Options Oncol. 2002;3:105-11.

Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. Int J Gynecol Obstet. 2006;95(1):43-103.

Van Nagell JR, Rayburn W, Donaldson ES, Hanson M, Gay EC, Yoneda J, et al. Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer. 1979;44(6):2354-61.

Hacker NF. Cervical cancer. In: Berek JS, Hacker NF, eds. Practical gynecologic oncology. 4th ed. Philadelphia, PA: Lippimcott Williams and Wilkins; 2005:265-336.

Hage WD, Aboulafia AJ, Aboulafia DM. Incidence, location, and diagnostic evaluation of metastic bone disease. Orhop Clin North Am. 2000;31:515-35.

Jason D Wright, Don S Dizon. Management of recurrent or metastatic cervical cancer. UpToDate [update Apr 06, 2015]. Available at:

Dornhöfer N, Höckel M. New developments in the surgical therapy of cervical carcinoma. Ann NY Acad Sci.2008;1138:233-52.

Höckel M. Pelvic recurrences of cervical cancer. Relapse pattern, prognostic factors and the role of extended radical treatment. J Pelv Surg. 1999;5:255-66.

Jain P, Hunter RD, Livsey JE, Coyle C, Swindell Rand Davidson SE. Salvaging locoregional recurrence with radio-therapy after surgery in early cervical cancer. Clin Oncol (RColl Radiol). 2007;19: 763-68.

Piura B, Rabinovich A, Friger M. Recurrent cervical carcinoma after radical hysterectomy and pelvic lymph node dissection: a study of 32 cases. Eur J Gynaecol Oncol. 2008;29:31-6.